Market Matters Ep. 12: How HIMS Could Benefit From FDA Changes

Raul Shah, CEO of DocShah Financial, analyzes the potential Wall Street implications of the FDA’s impending decision on peptide regulation, takes a closer look at how Hims & Hers could benefit from approval and shares his health care sector insights. Raul also explains why he still believes in UnitedHealth and why he’ll always be a value investor.

======== Schwab Network ========

Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe

Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185

Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7

Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch

Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore

Watch on DistroTV - https://www.distro.tv/live/schwab-network/

About Schwab Network - https://schwabnetwork.com/about

Fler avsnitt av Schwab Network